TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover | 0 | 5,868 | 0 |
Financial expenses | 3,784 | 8,686 | 3,437 |
Earnings before taxes | -18,442 | -63,657 | -53,545 |
EBITDA | -14,665 | -54,974 | -50,109 |
Total assets | 72,948 | 120,271 | 118,309 |
Current assets | 72,921 | 40,758 | 27,803 |
Current liabilities | 31,814 | 43,848 | 47,874 |
Equity capital | 41,132 | 76,079 | 69,413 |
- share capital | 1,775 | 1,306 | 863 |
Employees (average) | 7 | 8 | 6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency | 56.4% | 63.3% | 58.7% |
Turnover per employee | 0 | 734 | 0 |
Profit as a percentage of turnover | -1084.8% | ||
Return on assets (ROA) | -20.1% | -45.7% | -42.4% |
Current ratio | 229.2% | 93.0% | 58.1% |
Return on equity (ROE) | -44.8% | -83.7% | -77.1% |
Change turnover | -5,868 | 5,868 | 0 |
Change turnover % | -100% | ||
Chg. No. of employees | -1 | 2 | 0 |
Chg. No. of employees % | -13% | 33% | 0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.